title: [Antibiotics].
authors.affiliation: Department of Microbiology & Immunology, Teikyo University School of Medicine.
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Ono
mesh_terms: D000081:Acetamides / Q000009:adverse effects; D000617:Aminoglycosides / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002701:Chloramphenicol / Q000009:adverse effects; D005578:Fosfomycin / Q000009:adverse effects; D006020:Glycopeptides / Q000009:adverse effects; D006801:Humans; D048628:Ketolides / Q000009:adverse effects; D000069349:Linezolid; D018942:Macrolides / Q000009:adverse effects; D023303:Oxazolidinones / Q000009:adverse effects; D010455:Peptides / Q000009:adverse effects; D025361:Streptogramins / Q000009:adverse effects; D013754:Tetracyclines / Q000009:adverse effects; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects; D047090:beta-Lactams / Q000009:adverse effects
chemical_list: D000081:Acetamides; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D048628:Ketolides; D018942:Macrolides; D023303:Oxazolidinones; D010455:Peptides; D025361:Streptogramins; D013754:Tetracyclines; D047090:beta-Lactams; D005578:Fosfomycin; D002701:Chloramphenicol; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000069349:Linezolid